Direct importation of Glivec's copy product sought

The group of leukemia patients and the Glivec publicity group said recently that Glivec's copy drug "Veenat" was directly imported from Indo's Natco at a price of $2 per tablet and thus each leukemia patient would be able to take the drug for eight months (four-month treatment on two persons) at the cost of $1,900, within the ceiling import amount of the drug is set at $2,000 per patient.

Th...